MicrobiologyNature CommunicationsPeer-reviewed
Targeting the latent human cytomegalovirus reservoir with virus specific nanobodies
T. W. M. De Groof, E. G. Elder, R. Heukers…·M. J. Smit
This study develops a nanobody that partially inhibits HCMV receptor signaling and enhances T-cell killing of latently infected monocytes, offering a potential therapy for clearing HCMV reservoirs in transplant patients.
DOI 10.1038/s41467-021-24608-5